Clinical Case Reports (Aug 2020)

Management of a primary malignant melanoma of uterine cervix stage IVA patient with radical surgery and adjuvant oncolytic virus Rigvir® therapy: A case report

  • Elizabete Pumpure,
  • Eva Dručka,
  • Dana Kigitoviča,
  • Raimundas Meškauskas,
  • Sergejs Isajevs,
  • Ineta Nemiro,
  • Agnija Rasa,
  • Evija Olmane,
  • Tatjana Zablocka,
  • Pēteris Alberts,
  • Simona Doniņa

DOI
https://doi.org/10.1002/ccr3.2928
Journal volume & issue
Vol. 8, no. 8
pp. 1538 – 1543

Abstract

Read online

Abstract Primary malignant melanoma of the uterine cervix is a rare disease with poor prognosis and high recurrence rate. We used Rigvir® as adjuvant therapy for a stage IVA patient. Tolerability, overall and progression‐free survival are good.

Keywords